NK

Namrata Ketan Thaker

Director Director DIN 09118970
DIN 09118970 First appointment Aug 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2017
Shareholding value •••• Premium profile

About Namrata Ketan Thaker

Data last updated:

Namrata Ketan Thaker was a Director at Krish Healthcare Private Limited (2021–2025) and Partner at Kamlaamrut Buildcon Llp (2017–2018). The companies operate in Healthcare.

DIN 09118970
Primary Designation Director
Industry Healthcare
First Appointment 16 Aug 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Krish Healthcare Private Limited U85100GJ2021PTC121462
Director23 Mar 20212021₹1.17 Cr (FY 2025)Active
Partner16 Aug 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Krish Healthcare Private Limited
Kamlaamrut Buildcon Llp
Premium access

Shareholding and investment profile for Namrata Ketan Thaker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Namrata Ketan Thaker

Namrata Ketan Thaker was first appointed on 16 Aug 2017 as Partner at Kamlaamrut Buildcon Llp. The most recent appointment on record is 23 Mar 2021 at Krish Healthcare Private Limited.

Namrata Ketan Thaker held 2 earlier board appointments: Krish Healthcare Private Limited (Director, 23 Mar 2021 to 02 Jul 2025); Kamlaamrut Buildcon Llp (Partner, 16 Aug 2017 to 07 Feb 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available